Trends in Antimicrobial Susceptibility of Streptococcus pneumoniae in the Tohoku District of Japan: A Longitudinal Analysis from 1998 to 2007

  • Suzuki Kazumasa
    Department of Pathophysiology, Tohoku Pharmaceutical University
  • Nishimaki Katsushi
    Department of Infection Control and Laboratory Diagnostics, Internal Medicine, Tohoku University Graduate School of Medicine
  • Okuyama Kaori
    Department of Pathophysiology, Tohoku Pharmaceutical University
  • Katoh Tadashi
    Laboratory of Synthetic Medical Chemistry, Tohoku Pharmaceutical University
  • Yasujima Minoru
    Department of Laboratory Medicine, Hirosaki University Graduate School of Medicine
  • Chihara Junichi
    Department of Clinical and Laboratory Medicine, Akita University Graduate School of Medicine
  • Suwabe Akira
    Department of Laboratory Medicine, Iwate Medical University School of Medicine
  • Shibata Yoko
    Department of Cardiology, Pulmonology, and Nephrology, Yamagata University School of Medicine
  • Takahashi Choichiro
    Department of Clinical Laboratories, Yamagata University Hospital
  • Takeda Hiroaki
    Department of Respiratory Medicine, Yamagata Saisei Hospital, Yamagata, Japan
  • Ida Shiro
    Department of Internal Medicine, General Minami Tohoku Hospital
  • Kaku Mitsuo
    Department of Infection Control and Laboratory Diagnostics, Internal Medicine, Tohoku University Graduate School of Medicine
  • Watanabe Akira
    Research Division for Development of Anti-infective Agents, Institute of Development Aging and Cancer, Tohoku University
  • Nukiwa Toshihiro
    Department of Respiratory Medicine, Internal Medicine, Tohoku University Graduate School of Medicine
  • Niitsuma Kazunao
    Department of Internal Medicine, Fukushima Prefecture Aizu General Hospital
  • Kanemitsu Keiji
    Department of Clinical Laboratory Medicine, Fukushima Medical University
  • Takayanagi Motoaki
    Department of Pathophysiology, Tohoku Pharmaceutical University
  • Ohno Isao
    Department of Pathophysiology, Tohoku Pharmaceutical University

この論文をさがす

抄録

Streptococcus pneumoniae is a common cause of respiratory tract infections (RTIs). The prevalence of Streptococcus pneumoniae strains with reduced susceptibility to antimicrobial agents has dramatically increased worldwide. Susceptibility to nine antimicrobial agents and serotypes were determined among 1,644 Streptococcus pneumoniae strains isolated from patients with RTIs in the Tohoku district of Japan from October to December every year from 1998 to 2007. The prevalence of penicillin G-nonsusceptible Streptococcus pneumoniae (PNSP) strains increased gradually from 48.5% in 1998, reached a statistical peak in 2004 (65.1%) and then decreased to 51.5% in 2007. Streptococcus pneumoniae strains with each serotype 3, 6, 19 and 23 were constantly detected, and the distribution of these serotypes in PNSP strains did not significantly change during the study period. A trend of Streptococcus pneumoniae strains nonsusceptible to other β-lactams tested was similar to that of PNSP strains, except for cefditoren, to which the resistance rate was < 20% throughout the analysis period. The prevalence of strains nonsusceptible to erythromycin and minocycline were consistently > 60%. Almost all penicillin G-resistant Streptococcus pneumoniae (PRSP) strains were resistant to both erythromycin and minocycline throughout the analysis period. The prevalence of strains resistant to fluoroquinolones tested were < 3% over the study period. Our longitudinal surveillance demonstrated for the first time that decreased prevalence of both β-lactam- and multidrug-resistant strains has been occurring since 2004 in a region of Japan. Careful monitoring of antimicrobial susceptibility of Streptococcus pneumoniae should be continued.

収録刊行物

被引用文献 (1)*注記

もっと見る

参考文献 (78)*注記

もっと見る

関連プロジェクト

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ